CHEN Chen,ZHANG Hua,YE Jian,et al.Effect of saikosaponin a on aortic plaque formation in mice with atherosclerosis and depression[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(04):86-91.
CHEN Chen,ZHANG Hua,YE Jian,et al.Effect of saikosaponin a on aortic plaque formation in mice with atherosclerosis and depression[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(04):86-91. DOI: 10.16305/j.1007-1334.2022.2108097.
Effect of saikosaponin a on aortic plaque formation in mice with atherosclerosis and depression
Objective,2,To explore the effect and mechanism of depression on atherosclerosis(AS), and explore the effect and possible mechanism of saikosaponin a (SSa) on AS in mice with AS complicated with depression.,Methods,2,①Thirty male Apoe,-/-, mice were randomly divided into AS group (,n,=6) and AS complicated with depression group (,n,=24), and the AS group was administered with high-fat diet for 8 weeks and chronic unpredictable mild stress (CUMS) to establish the AS with depression mouse model. After the model was established successfully, the body mass, blood lipid (TC, LDL-C) level, serum CRP level were compared and aortic atherosclerosis were observed by HE staining and compared between AS group and AS complicated with depression group. ②AS complicated with depression group (,n,=18) was randomly divided into a normal saline (SLYS) group (,n,=6), a fluoxetine (FXT) group (,n,=6) and a SSa group (,n,=6). After 4 weeks of intragastric administration of SSa, fluoxetine and 0.9% NaCl solution 5 mg·kg,-1,·d,-1, in the corresponding groups, the body mass, serum levels of blood lipid (TC, LDL-C) and CRP were compared, aortic atherosclerosis was observed by HE staining, NLRP3 content in aortic plaque was observed by immunohistochemical staining, and animal behavior was evaluated by tail suspension test and forced swimming test.,Results,2,①The body mass and serum TC, LDL-C, CRP levels in AS complicated with depression group were higher than those in AS group (,P,<,0.05); The degree of aortic atherosclerosis in AS complicated with depression group was significantly higher than that in AS group. ②After 4 weeks of intervention with corresponding drugs, the body mass and LDL-C level of AS and depression mice in SSa group were lower than those in FXT group (,P,<,0.05); serum CRP level of AS and depression mice in SSa group was lower than that in SLYS group (,P,<,0.05); the degree of aortic atherosclerosis of AS and depression mice in SSa group was milder than that in FXT Group and SLYS Group, and the expression of NLRP3 in AS plaque of AS and depression mice in SSa group was less than that of FXT group and SLYS group (,P,<,0.05); the rest time of forced swimming and tail suspension in SSa group was shorter than that in SLYS group and FXT group (,P,<,0.05).,Conclusions,2,Depression can increase body mass and blood lipid level, enhance inflammatory reaction and aggravate AS. SSa can significantly improve depression, and may alleviate AS by reducing the inflammatory reaction of mice with AS and depression through lowering the expression of NLRP3.
关键词
柴胡皂苷a抑郁动脉粥样硬化模型小鼠中药研究
Keywords
saikosaponin adepressionatherosclerosismodel mousetraditional Chinese herbal medicine research
references
GAN Y, GONG Y, TONG X, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies[J]. BMC Psychiatry, 2014(14): 371.
RAMI M, GUILLAMAT-PRATS R, RINNE P, et al. Chronic intake of the selective serotonin reuptake inhibitor fluoxetine enhances atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2018, 38(5): 1007-1019.
CHEN X Q, CHEN S J, LIANG W N, et al. Saikosaponin a attenuates perimenopausal depression-like symptoms by chronic unpredictable mild stress[J]. Neurosci Lett, 2018(662): 283-289.
WANG Y S, SHEN C Y, JIANG J G. Antidepressant active ingredients from herbs and nutraceuticals used in TCM: pharmacological mechanisms and prospects for drug discovery[J]. Pharmacol Res, 2019(150): 104520.
NAKASHIMA Y, PLUMP A S, RAINES E W, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree[J]. Arterioscler Thromb, 1994, 14(1): 133-140.
HARSHFIELD E L, PENNELLS L, SCHWARTZ J E, et al. Association between depressive symptoms and incident cardiovascular diseases[J]. JAMA, 2020, 324(23): 2396-2405.
SMOLDEREN K G, BUCHANAN D M, GOSCH K, et al. Depression treatment and 1-year mortality after acute myocardial infarction: insights from the TRIUMPH registry(translational research investigating underlying disparities in acute myocardial infarction patients' health status)[J]. Circulation, 2017, 135(18): 1681-1689.
MALIK J, SHARIF KHAN H, YOUNUS F, et al. From heartbreak to heart disease: a narrative review on depression as an adjunct to cardiovascular disease[J]. Pulse(Basel), 2021, 8(3-4): 86-91.
BEHLKE L M, LENZE E J, CARNEY R M. The cardiovascular effects of newer antidepressants in older adults and those with or at high risk for cardiovascular diseases[J]. CNS Drugs, 2020, 34(11): 1133-1147.
CARNEY R M, FREEDLAND K E. Depression and coronary heart disease[J]. Nat Rev Cardiol, 2017, 14(3): 145-155.
PENNINX B W. Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms[J]. Neurosci Biobehav Rev, 2017, 74(Pt B): 277-286.
KAUFMANN F N, COSTA A P, GHISLENI G, et al. NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings[J]. Brain Behav Immun, 2017(64): 367-383.
KOO J W, WOHLEB E S. How stress shapes neuroimmune function: implications for the neurobiology of psychiatric disorders[J]. Biol Psychiatry, 2021, 90(2): 74-84.
BEUREL E, TOUPS M, NEMEROFF C B. The bidirectional relationship of depression and inflammation: double trouble[J]. Neuron, 2020, 107(2): 234-256.
STITHAM J, RODRIGUEZ-VELEZ A, ZHANG X, et al. Inflammasomes: a preclinical assessment of targeting in atherosclerosis[J]. Expert Opin Ther Targets, 2020, 24(9): 825-844.
ROY P, ORECCHIONI M, LEY K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity[J/OL]. Nat Rev Immunol, 2021[2021-08-15]. https://www.nature.com/articles/s41577-021-00584-1https://www.nature.com/articles/s41577-021-00584-1.
GREBE A, HOSS F, LATZ E. NLRP3 Inflammasome and the IL-1 pathway in atherosclerosis[J]. Circ Res, 2018, 122(12): 1722-1740.
VAN DER HEIJDEN T, KRITIKOU E, VENEMA W, et al. NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein e-deficient mice-brief report[J]. Arterioscler Thromb Vasc Biol, 2017, 37(8): 1457-1461.
Mechanisms of Erlong Zuoci Wan alleviating damage to cochlear spiral ganglion neurons by upregulation of SIRT1 in mice with presbycusis
Experiment study on Yiqi Fuzheng Prescription in anti⁃lung cancer metastasis by regulating the polarization of tumor associated macrophages
Effects of Xinqian Ganjie Decoction on lncRNASNHG16, EGFR and MUC5AC mRNA expression in chronic rhinosinusitis mice
Mechanism of Yucan Granules improving podocyte damage and treating diabetic nephropathy
Mechanism of Huangqi Decoction against liver fibrosis by network pharmacological analysis combined with related cell experiment
Related Author
No data
Related Institution
School of Integrative Medicine Sciences, Shanghai University of Traditional Chinese Medicine
School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
Shanghai Experimental Animal Research Center
Second Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Department of Otolaryngology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine